Vaccine developer SK Bioscience to raise $1.3 bln in IPO

SK Chemicals

08/03/2021 07:07

SEOUL, March 8 (Reuters) - South Korean vaccine developer SK
Bioscience Co Ltd is expected to raise 1.5 trillion won ($1.33
billion) in an initial public offering (IPO) after pricing the
listing at the top of an indicative range, it said on Monday. 
    SK Bioscience said in a regulatory filing that it had priced
the IPO at 65,000 won per share, compared to an indicative 
range of 49,000-65,000 won per share. 
    
    ($1 = 1,128.3500 won)

 (Reporting by Joyce Lee; Editing by Himani Sarkar)
 ((jungyoon.lee@tr.com; +82 2 6936 1467;))